New buy­ers lin­ing up bids for No­var­tis' gi­ant gener­ics arm

4 years ago
Pharma

Re­ci­phar­m's glob­al deal spree con­tin­ues with ac­qui­si­tion of Por­tuguese CD­MO

4 years ago
Manufacturing

Af­ter deal shield­ing Sack­lers from fur­ther lit­i­ga­tion over­turned, fam­i­ly mem­bers to pour more mon­ey in­to set­tle­ment

4 years ago
Pharma

Up­dat­ed: Con­tro­ver­sial opi­oid Zo­hy­dro ER pulled from the mar­ket

4 years ago
R&D

Bak­er's dozen: Pfiz­er joins 12 peers in re­strict­ing sales of dis­count­ed drugs un­der a fed­er­al pro­gram

4 years ago
R&D

Pfiz­er raids Roche ex­ec­u­tive com­mit­tee for new drug de­vel­op­ment chief — and Schwan plucks his re­place­ment from the ...

4 years ago
People
Pharma

Bio­gen leaps in­to a show­down be­tween Roche and Re­gen­eron, bet­ting on a po­ten­tial new fran­chise play­er

4 years ago
Pharma
FDA+

Mar­ket­ingRx Q&A: Evofem CEO Saun­dra Pel­leti­er on frank con­ver­sa­tions and dis­rupt­ing the con­tra­cep­tion mar­ket

4 years ago
Pharma
Marketing

Mar­ket­ingRx roundup: Ho­log­ic goes to the Su­per Bowl with Mary J. Blige; Hori­zon bows Graves’ dis­ease TV ad

4 years ago
Pharma
Marketing

How UCB beat 2 oth­er bid­ders to land $1.9B buy­out of Zo­genix and its epilep­sy drug

4 years ago
Deals

Mar­tin Shkre­li-as­so­ci­at­ed com­pa­nies set­tle an­ti-com­pet­i­tive law­suit with in­sur­er for $28M

4 years ago
People

Af­ter land­ing funds from Roy­al­ty, Cy­to­ki­net­ics an­nounces afi­camten PhII re­sults; Pol­ish CRO Selvi­ta re­struc­tures in ...

4 years ago
News Briefing

Re­cent­ly stung by AAV, Sarep­ta dives a lit­tle deep­er in­to non-vi­ral de­liv­ery with newest li­cens­ing pact

4 years ago
Deals
Cell/Gene Tx

FDA ex­pands la­bel for Vi­iV's Cabe­nu­va to cov­er bi-month­ly ad­min­is­tra­tion HIV treat­ment

4 years ago
Pharma

Weight loss spin­out Gele­sis ditch­es pro­mo­tion­al staff af­ter SPAC fail — re­port

4 years ago
Pharma
Marketing

Covid-19 roundup: Vac­cine for the youngest kids may be com­ing soon; Mod­er­na wins PRV with full ap­proval

4 years ago
Coronavirus

Trou­bled Alzheimer's play­er Cor­texyme says good­bye to found­ing team as in­de­pen­dent in­vestor takes chair­man­ship

4 years ago
People

Or­p­hazyme CEO de­parts for Leo Phar­ma as both com­pa­nies face ma­jor re­struc­tur­ings

4 years ago
R&D

Af­ter sput­ter­ing on the launch pad, No­vavax fi­nal­ly gets its EUA ap­pli­ca­tion in. Does it mat­ter?

4 years ago
FDA+
Coronavirus

DARPA deputy re­turns home to the UK to lead a new $1B gov­ern­ment re­search agency

4 years ago
People

Ho­log­ic plans Su­per Bowl ad with Mary J. Blige to show women ‘Re­al Love’ means health check­ups

4 years ago
Pharma
Marketing

Take­da spins PhII rare dis­ease pro­grams in­to new start­up — send­ing 2 ex­ecs and some cash to get things go­ing

4 years ago
Startups

Biotech's very bad start to the year con­tin­ues as mi­cro­cap gene ther­a­py play­er Sio ditch­es CEO, lead part­ner­ship

4 years ago
People
R&D

As­traZeneca adds chron­ic kid­ney dis­ease TV ad to Farx­i­ga port­fo­lio

4 years ago
Pharma
Marketing
First page Previous page 590591592593594595596 Next page Last page
A service from the Financial Times